The Dermatology Digest

APRIL 4, 2024

The safety profile of Bimzelx was consistent with previous studies with no new safety signals observed. in October 2023 for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Bimzelx was approved in the U.S. Bimzelx is not approved in the U.S.

Safety 57

Safety Injections Clinic Therapy 57

The Dermatology Digest

FEBRUARY 14, 2024

This follows its designation as a Breakthrough Therapy for the treatment of pruritus associated with prurigo nodularis, originally granted in December 2019 and reconfirmed in March 2023. Nemolizumab was generally well tolerated and its safety profile was similar to placebo across the OLYMPIA and ARCADIA clinical trial programs.

Dermatitis 78

Dermatitis Clinic Safety Dermatology 78

The Dermatology Digest

JULY 10, 2024

The interleukin-13 blocker is indicated for the treatment of adult and adolescent patients (12 years and older with a body weight of at least 40 kg) with moderate to severe AD, who are candidates for systemic therapy. The letter stated no concerns about the clinical data package, safety, or label for lebrikizumab.

Dermatitis 36

Dermatitis Safety Dermatology Marketing 36

New Age Spa Institute

JUNE 13, 2024

Each state has its own requirements for training programs and licensing exams, so it’s important to check with the specific state board of esthetics, cosmetology, massage therapy, and nail technology for detailed regulations and any updates. Stay tuned! Accreditation has nothing to do with the state board licensing.

Continuing Education 52

Continuing Education Continuous Education Education Esthetics 52

The Dermatology Digest

DECEMBER 18, 2023

The new AD guidelines also: • Highlight the safety of the topical calcineurin inhibitors with typical usage once or twice daily. Recommend proactive therapy with topical corticosteroids or topical calcineurin inhibitors for patients with a relapsing course of AD. Urge consideration for once-daily dosing of topical medications.

Dermatitis 36

Dermatitis Partnerships Therapy Diet 36

The Dermatology Digest

FEBRUARY 7, 2024

The total duration of the trial was up to 24 weeks, which included a four-week screening period, a 16-week treatment period and a four-week safety follow-up period. and Janssen Biotech, Inc. The findings from the FRONTIER 1 clinical trial suggest the potential of JNJ-2113 across the spectrum of additional IL-23-mediated diseases.

Safety 36

Safety Clinic Office Dermatology 36

The Dermatology Digest

MARCH 11, 2024

This follows its designation as a Breakthrough Therapy for the treatment of pruritus associated with prurigo nodularis, originally granted in December 2019 and reconfirmed in March 2023. No new safety signals were observed in this trial.

Dermatitis 36

Dermatitis Safety Eczema Dermatology 36

Aesthetics Advisor

SEPTEMBER 7, 2023

The New England Journal of Medicine - The buzz was palpable at the 2023 American Diabetes Association Scientific Sessions as multiple new nutrient-stimulated, hormone-based therapies for obesity and type 2 diabetes took center stage. N Engl J Med 2023 ;389: 514 - 526. Lancet 2023 June 26 (Epub ahead of print).

Surgery 36

Surgery Therapy Management Sustainability 36

The Dermatology Digest

OCTOBER 5, 2023

Barr, MD, dual board-certified integrative dermatologist, certified somatic trauma therapy practitioner, Somatic Skin Science, Seattle, Washington. “It ” session at the 2023 AAD Innovation Academy in Tampa, Florida. “I Essentially a resource is anything that helps you and your patients feel a sense of safety and support.

Safety 36

Safety Social Media Therapy Sun Protection 36

The Dermatology Digest

JANUARY 10, 2024

Positive clinical data from the Phase 1b trial were announced in October 2023. The trial was a 16-week open-label study assessing the safety, tolerability, pharmacokinetics, and exploratory efficacy of once-daily topical VYN201 in 29 patients with a clinical diagnosis of active nonsegmental vitiligo, in three dose cohorts (0.5%, 1.0%

Clinic 36

Clinic Safety Dermatology Facials 36

Spa Executive

AUGUST 28, 2023

In his Talent Talk at ISPA 2023, Smiley Poswolsky made the case for employee belonging. She just moved here from Texas and she’s big into hot-cold therapy and ice baths/K-Pop/football. Are your employees lonely? This is Noor. You should get along great!”

Hospital 52

Hospital Management Safety Irritation 52

Aesthetics Advisor

JUNE 16, 2024

As with so many skin-care trends that have come before, this one is rooted in medicine — in this case, regenerative medicine, which is centered on developing and applying therapies to help the body heal itself. But the authors also noted that “further studies are needed to assess the long-term efficacy and safety of this technique.”

Injections 36

Injections Aromatherapy Ingredients Moisturization 36

Aesthetics Advisor

FEBRUARY 21, 2024

coli, listeria and salmonella, and as such have been used in food products to enhance safety. Sources and References 1 Tasting Table September 1, 2023 2, 20 Int J Mol Sci. 2023 Sep-Oct;17(5):23-30 13, 14 Foods. Further, papain and other papaya extracts have antibacterial properties against multiple enteropathogens, including E.

Extractions 36

Extractions Vitamin C Diet Irritation 36

Aesthetics Advisor

JUNE 18, 2024

Consider medical treatments: Fillers, laser therapy, and surgery may be required for severe or persistent dark circles. 282/016) Caudalie Vinergetic C+ Brightening Eye Cream Reviews Spacenk.com Ika stafu - November 10 2023 Definitely less dark circles under my eyes & less puffy Sylwia - November 02 2022 Love this particular product.

Vitamin C 36

Vitamin C Extractions Hydration Makeup 36

Aesthetics Advisor

AUGUST 15, 2023

Curcumin may help increase healthy p53 levels, and it has been shown to be a potentially effective cancer therapy supplement. Since fenbendazole is a veterinary medicine, and is not licensed for human use and there is no specific human safety data available. Click here to buy Theracurmin HP by Integrative Therapeutics (Amazon) 3.

Therapy 69

Therapy Medical Safety Diet 69

Aesthetics Advisor

AUGUST 19, 2023

As of August 2023, there are more than 29,000 studies published related to exosome and more than 14,000 studies related to PRP on PubMed (US NIH Library of Medicine Database). Nevertheless, PRP and exosome-related therapies are not yet established as standard treatments, given their relatively recent emergence. What is PRP?

Therapy 36

Therapy Injections Medical Treatments 36

Aesthetics Advisor

AUGUST 16, 2023

The AAP guidance recommends “comprehensive treatment,” which includes nutrition support, physical activity, behavioral therapy, medications and metabolic and bariatric surgery. January 9, 2023 13 Associated Press January 9, 2023 15 Pediatrics e2022060641. 2023 Mar 28. 2023 Mar 28. 2020 May 28;181(5):1112-1130.e16.

Injections 36

Injections Pharmaceutical Medical Surgery 36

First Derm

JANUARY 16, 2024

Patient Safety and Success : Prioritizing skin cancer screening helps in safeguarding patient health, significantly enhancing the safety and success rates of cosmetic procedures. Compromised surgical outcomes: Performing cosmetic procedures on skin with undetected cancer can compromise the safety and effectiveness of the surgery.

Surgery 45

Surgery Scarring Safety Consultation 45

First Derm

NOVEMBER 25, 2023

Relationship impact : honesty and safety measures are key. 20] The American College of Obstetricians and Gynecologists (ACOG) emphasizes the significant morbidity and mortality caused by HPV and strongly recommends HPV vaccination to eligible patients, stressing the benefits and safety of the vaccine. Accessed November 20, 2023.

Safety 45

Safety Education Clinic Therapy 45

First Derm

DECEMBER 26, 2023

Hormonal therapies. Accessed December 26, 2023. Evaluation of safety and efficacy of ketoconazole 2% and zinc pyrithione 1% shampoo in patients with moderate to severe dandruff–a postmarketing study. Accessed December 26, 2023. Published September 4, 2023. Accessed December 26, 2023. Antibiotics.

Management 49

Management Dermatitis Eczema Consultation 49

The Dermatology Digest

SEPTEMBER 13, 2024

Image-guided superficial radiation therapy (IGSRT or Image-Guided SRT) keeps nonmelanoma skin cancer (NMSC) recurrences at bay, according to new research. For the large retrospective cohort study, researchers culled treatment records for nearly 20,000 NMSC lesions from 28 institutions in 12 states from 2016 to 2023.

Surgery 36

Surgery Therapy Safety Clinic 36

Starpil Wax

JUNE 2, 2023

As a licensed esthetician , client safety and comfort should always be your first priority. This sort of care can include anything from hair removal, to hormone replacement therapy (HRT), or gender-related counseling services. What are Gender-Affirming Waxing Services? And when I say any questions, I really mean any!

Salon 52

Salon Waxing Hair Removal Esthetician 52

Aesthetics Advisor

FEBRUARY 28, 2024

Dr. Suzanne Humphries published a special report on the treatment of whooping cough and Orthomolecular Medical News proposed intravenous vitamin C as a cancer therapy. In 2014, Alpha Fowler from Virginia Commonwealth University and his team published Phase 1 safety trials for the IV administration of vitamin C in patients with sepsis.

Vitamin C 36

Vitamin C Pharmaceutical Hospital Therapy 36

Aesthetics Advisor

JANUARY 6, 2024

In November 2023, researchers from Cardiff University in the United Kingdom published a comprehensive review in the British Journal of Cancer (BJC) outlining aspirin’s potential to reduce cancer mortality, prevent metastatic cancer spread, and minimize vascular complications.

Vitamin C 36

Vitamin C Safety Therapy Networking 36

Aesthetics Advisor

FEBRUARY 13, 2024

Once reserved for the world's pro athletes and billionaires, the global Stem Cell Therapy market size was exhibited at USD 12.9 billion by 2032, growing at a CAGR of 13.74% during the forecast period 2023 to 2032. ( billion by 2032, growing at a CAGR of 13.74% during the forecast period 2023 to 2032. (

Diet 36

Diet Vitamin C Extractions Therapy 36

Aesthetics Advisor

SEPTEMBER 1, 2023

pylori activity, comparable to triple eradication therapy. [ Colon cancer: Cell studies have found that black seed extract compares favorably to the chemo agent 5-fluorouracil in the suppression of colon cancer growth, but with a far higher safety profile. [10]

Extractions 36

Extractions Social Media Therapy Clinic 36

The Dermatology Digest

FEBRUARY 8, 2024

In 2023, dermatologists and their patients welcomed new drugs for acne, psoriasis, alopecia areata, and more, and 2024 promises to deliver real-world data on these medications along with even more therapeutic innovations across the spectrum of cutaneous diseases. And the Skin Disease of the Year Is…. Taking Seb Derm Seriously The U.S.

Dermatology 78

Dermatology Eczema Pharmaceutical Dermatitis 78

Aesthetics Advisor

OCTOBER 7, 2023

The multiple therapies and drugs in this protocol have different mechanisms of action and work synergistically during various phases of the disease. The I-Care protocol has been updated and below is their latest version (March 30, 2023). First Line Therapies (In order of priority; not all required.) Ivermectin: 0.4

Treatments 69

Treatments Therapy Medical Vitamin C 69

The Dermatology Digest

NOVEMBER 14, 2024

The interleukin 17A (IL-17A) and IL-17F blocker was approvedfor the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy in Oct. Fatigue was assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue subscale (FACIT-Fatigue).

Sustainability 74

Sustainability Safety Clinic Therapy 74

The Dermatology Digest

NOVEMBER 20, 2024

The approval of bimekizumab-bkzx blocker is supported by data from two Phase 3 studies, BE HEARD I and BE HEARD II, which evaluated the efficacy and safety of bimekizumab in the treatment of adults with moderate-to-severe HS. living with moderate-to-severe disease,” says Brindley Brooks, Founder and Executive Director of HS Connect.

Safety 78

Safety Sustainability Clinic Medical 78

The Dermatology Digest

APRIL 10, 2025

Dermatologists rely heavily on topical therapies for cutaneous lupus erythematosus (CLE), but are increasing interested in systemic agents with user-friendly formulations and dermatology-relevant experience such as deucravacitinib (Sotyktu BMS), an oral TYK2 inhibitor currently approved for psoriasis.

Therapy 36

Therapy Safety Dermatology Management 36

Aesthetics Advisor

APRIL 3, 2025

This dual action amplifies tirzepatides effects on glucose control and weight loss compared to GLP-1-only therapies like semaglutide. Long-term safety data, including cancer risk, is still under investigation, but its anti-tumor effects in preclinical models are promising. mg weekly dose. Which Drug Is Right for You?

Safety 36

Safety Sustainability Marketing Management 36

The Dermatology Digest

FEBRUARY 7, 2025

Data collected will enable research to help better understand the burden of disease for AA patients, as well as the real-world effectiveness and safety of newly approved treatments. It complements an existing CorEvitas registry focused on AA in adults, launched in 2023. The registry is now active in both Europe and the U.S.,

Clinic 28

Clinic Safety Dermatology Medical 28

Aesthetics Advisor

NOVEMBER 16, 2023

Update: Doctors Can Prescribe Ivermectin for COVID-19: FDA Lawyer (August 2023) If you are confused about the recommendations made by different professional groups for the COVID-19 pandemic and you don't accept what you read at face value, you've come to the right place. Related: Best Vitamin D3 Supplement 2. Quercetin is also no.

Vitamin C 69

Vitamin C Hospital Safety Medical 69